Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinastine Hydrochloride Eye Drops in Chinese Seasonal Allergic Conjunctivitis
NCT06212973Phase 3Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- Mar 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epinastine in seasonal allergic conjunctivitis (SAC), sponsored by Zhaoke Ophthalmology. Started Mar 2023; status: completed.
02
Drugs
epinastine
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on NCT06212973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06212973.